Advertisement

Press Release

ASHP Publishes New Edition of Extended Stability for Parental Drugs

Fifth Edition Includes New and Expanded Material

4/25/2013

The American Society of Health-System Pharmacists (ASHP) has published a new edition of its Extended Stability for Parenteral Drugs, a valuable reference for anyone working in alternate site infusion or preparing sterile compounds. The fifth edition, by Caryn Marie Dellamorte Bing, M.S., FASHP, and Anna Nowobilski-Vasilios, Pharm.D., MBA, FASHP, CNSC, BSNCP, is designed to help pharmacists safely extend beyond-use dating of parenteral medications to minimize waste and reduce costs.

With expanded tables and enhanced references, Extended Stability for Parenteral Drugs is the only publication that brings key stability data on the most commonly used IV solutions, medications, and administration devices together in one convenient, easy-to-use guide.

Other new features in the text include:
 
  • 160 updated monographs, including the following 10 that are new to this edition:
    • Acetaminophen
    • Ceftaroline fosamil
    • Coagulation Factor XIII
    • Doripenem
    • Ethanol lock
    • Ibuprofen
    • Pantoprazole
    • Telavancin
    • Toclizumab
    • Ziconotide acetate
  • 24 parenteral nutrition monographs, including additional considerations for calcium and phosphate solubility,
  • Monograph updates, including revisions to several container types and new information for elastometric infusion device brands,
  • A new portion of the “Applying Stability Data in Patient Care” section that includes a nursing perspective, a primer on the types of vascular access devices used in medication administration, and important considerations for pH, osmolality, concentration, and administration devices.
To place orders for the book (ISBN: 978-1-58528-340-8) and view additional material, please visit www.ashp.org/stability. Or, please email custserv@ashp.org or call 1-866-279-0681 (U.S. & Canada), 001-301-664-8700 (International). To arrange an interview, book signing, or to discuss co-marketing or bulk sales, please contact Rachel Gellman at rgellman@ashp.org

About the Authors
 
Caryn Marie Dellamorte Bing, R.Ph., M.S., FASHP, holds a B.S. from University of Illinois College of Pharmacy, an M.S. in Health Systems Management from Rush University, and completed a pharmacy residency at Rush-Presbyterian-St. Luke’s Medical Center in Chicago.  Bing has over 25 years of practice, management, and leadership experience in alternate site pharmacy services. She is currently corporate clinical services/residency program manager at Critical Care Systems, a national home and specialty infusion provider. 
 
Anna Nowobilski-Vasilios, Pharm.D., MBA, FASHP, CNSC, BSNCP, principal at Anovation, Inc, a surveyor for the Accreditation Commission for Health Care, and adjunct assistant professor at Midwestern University. Her experience includes over 30 years in pharmacy and over 25 years in home infusion and specialty pharmacy services. Nowobilski-Vasilios worked at Option Care for 14 years, culminating as senior vice president for care management services. She also held management and clinical positions with other regional and national home infusion providers and in hospital pharmacy practice. She holds a B.S. in pharmacy from the University of Illinois, an M.B.A. from Keller Graduate School of Management, and a Pharm.D. from Midwestern University. She is a Rho Chi Scholar and is board-certified in both nutrition support and nutrition support pharmacy. 

About ASHP
 
ASHP is the national professional organization whose 40,000 members include pharmacists, pharmacy technicians, and pharmacy students who provide patient care services in hospitals, health systems, and ambulatory clinics. For 70 years, the Society has been on the forefront of efforts to improve medication use and enhance patient safety. For more information about the wide array of ASHP activities and the many ways in which pharmacists help people make the best use of medicines, visit ASHP's website, www.ashp.org, or its consumer website, www.safemedication.com.
 
-END-

 

Contact Us
For questions, comments, or more information on this article, please contact the Public Relations Office via telephone at 301-664-8799 or via e-mail at publicinfo@ashp.org.
Advertisement